657 related articles for article (PubMed ID: 34502127)
1. Molecular Biological and Clinical Understanding of the Pathophysiology and Treatments of Hyperuricemia and Its Association with Metabolic Syndrome, Cardiovascular Diseases and Chronic Kidney Disease.
Yanai H; Adachi H; Hakoshima M; Katsuyama H
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502127
[TBL] [Abstract][Full Text] [Related]
2. Role of asymptomatic hyperuricemia in the progression of chronic kidney disease and cardiovascular disease.
Waheed Y; Yang F; Sun D
Korean J Intern Med; 2021 Nov; 36(6):1281-1293. PubMed ID: 33045808
[TBL] [Abstract][Full Text] [Related]
3. Uric acid metabolism in pre-hypertension and the metabolic syndrome.
Rizzo M; Obradovic M; Labudovic-Borovic M; Nikolic D; Montalto G; Rizvi AA; Mikhailidis DP; Isenovic ER
Curr Vasc Pharmacol; 2014; 12(4):572-85. PubMed ID: 23627979
[TBL] [Abstract][Full Text] [Related]
4. Hyperuricemia and the progression of chronic kidney disease: is uric acid a marker or an independent risk factor?
Nashar K; Fried LF
Adv Chronic Kidney Dis; 2012 Nov; 19(6):386-91. PubMed ID: 23089273
[TBL] [Abstract][Full Text] [Related]
5. Urate Transporter 1 Can Be a Therapeutic Target Molecule for Chronic Kidney Disease and Diabetic Kidney Disease: A Retrospective Longitudinal Study.
Yanai H; Katsuyama H; Hakoshima M; Adachi H
Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36831103
[TBL] [Abstract][Full Text] [Related]
6. High uric acid level is a risk factor for progression of IgA nephropathy with chronic kidney disease stage G3a.
Moriyama T; Itabashi M; Takei T; Kataoka H; Sato M; Shimizu A; Iwabuchi Y; Nishida M; Uchida K; Nitta K
J Nephrol; 2015 Aug; 28(4):451-6. PubMed ID: 25355499
[TBL] [Abstract][Full Text] [Related]
7. Only Hyperuricemia with Crystalluria, but not Asymptomatic Hyperuricemia, Drives Progression of Chronic Kidney Disease.
Sellmayr M; Hernandez Petzsche MR; Ma Q; Krüger N; Liapis H; Brink A; Lenz B; Angelotti ML; Gnemmi V; Kuppe C; Kim H; Bindels EMJ; Tajti F; Saez-Rodriguez J; Lech M; Kramann R; Romagnani P; Anders HJ; Steiger S
J Am Soc Nephrol; 2020 Dec; 31(12):2773-2792. PubMed ID: 32938648
[TBL] [Abstract][Full Text] [Related]
8. Dotinurad: a novel selective urate reabsorption inhibitor as a future therapeutic option for hyperuricemia.
Kuriyama S
Clin Exp Nephrol; 2020 Mar; 24(Suppl 1):1-5. PubMed ID: 31754883
[TBL] [Abstract][Full Text] [Related]
9. Excess Uric Acid Induces Gouty Nephropathy Through Crystal Formation: A Review of Recent Insights.
Mei Y; Dong B; Geng Z; Xu L
Front Endocrinol (Lausanne); 2022; 13():911968. PubMed ID: 35909538
[TBL] [Abstract][Full Text] [Related]
10. Hyperuricemia, the heart, and the kidneys - to treat or not to treat?
Petreski T; Ekart R; Hojs R; Bevc S
Ren Fail; 2020 Nov; 42(1):978-986. PubMed ID: 32972284
[TBL] [Abstract][Full Text] [Related]
11. Electrochemical analysis of uric acid excretion to the intestinal lumen: Effect of serum uric acid-lowering drugs and 5/6 nephrectomy on intestinal uric acid levels.
Fujita K; Yamada H; Iijima M; Ichida K
PLoS One; 2019; 14(12):e0226918. PubMed ID: 31891613
[TBL] [Abstract][Full Text] [Related]
12. Hyperuricemia and Cardiovascular Disease.
Zhang S; Wang Y; Cheng J; Huangfu N; Zhao R; Xu Z; Zhang F; Zheng W; Zhang D
Curr Pharm Des; 2019; 25(6):700-709. PubMed ID: 30961478
[TBL] [Abstract][Full Text] [Related]
13. Dendrobium officinalis six nostrum ameliorates urate under-excretion and protects renal dysfunction in lipid emulsion-induced hyperuricemic rats.
Chen X; Ge HZ; Lei SS; Jiang ZT; Su J; He X; Zheng X; Wang HY; Yu QX; Li B; Lv GY; Chen SH
Biomed Pharmacother; 2020 Dec; 132():110765. PubMed ID: 33120237
[TBL] [Abstract][Full Text] [Related]
14. Baicalein alleviates hyperuricemia by promoting uric acid excretion and inhibiting xanthine oxidase.
Chen Y; Zhao Z; Li Y; Yang Y; Li L; Jiang Y; Lin C; Cao Y; Zhou P; Tian Y; Wu T; Pang J
Phytomedicine; 2021 Jan; 80():153374. PubMed ID: 33075645
[TBL] [Abstract][Full Text] [Related]
15. Hyperuricemia, Hypertension, and Chronic Kidney Disease: an Emerging Association.
Mallat SG; Al Kattar S; Tanios BY; Jurjus A
Curr Hypertens Rep; 2016 Oct; 18(10):74. PubMed ID: 27696189
[TBL] [Abstract][Full Text] [Related]
16. Different clinical impact of hyperuricemia according to etiologies of chronic kidney disease: Gonryo Study.
Watanabe K; Nakayama M; Yamamoto T; Yamada G; Sato H; Miyazaki M; Ito S
PLoS One; 2021; 16(3):e0249240. PubMed ID: 33765101
[TBL] [Abstract][Full Text] [Related]
17. Time to target uric acid to retard CKD progression.
Kumagai T; Ota T; Tamura Y; Chang WX; Shibata S; Uchida S
Clin Exp Nephrol; 2017 Apr; 21(2):182-192. PubMed ID: 27339448
[TBL] [Abstract][Full Text] [Related]
18. Time to Target Uric Acid to Retard Chronic Kidney Disease Progression.
Uchida S; Kumagai T; Chang WX; Tamura Y; Shibata S
Contrib Nephrol; 2018; 192():56-68. PubMed ID: 29393121
[TBL] [Abstract][Full Text] [Related]
19. Associations Between Serum Uric Acid Concentrations and Cardiometabolic Risk and Renal Injury in Obese and Overweight Children.
Özalp Kızılay D; Şen S; Ersoy B
J Clin Res Pediatr Endocrinol; 2019 Sep; 11(3):262-269. PubMed ID: 30759960
[TBL] [Abstract][Full Text] [Related]
20. Renal Effects of Hyperuricemia.
Méndez Landa CE
Contrib Nephrol; 2018; 192():8-16. PubMed ID: 29393089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]